A CKD stage number on a lab report doesn’t mean much without context. Stage 3 sounds alarming to some patients and gets dismissed too casually by others, when really, what matters is understanding what the number reflects, how it’s likely to change over time, and what that means for your care decisions. This guide breaks down how CKD staging actually works and how it should inform monitoring and treatment.
eGFR and Albuminuria: The Two Numbers That Matter Most
CKD staging isn’t based on a single test, it combines two separate measurements that each tell a different part of the story.
| Measurement | What It Reflects |
| eGFR (estimated Glomerular Filtration Rate) | How well your kidneys are filtering blood, calculated from blood creatinine, age, and sex |
| Albuminuria (urine albumin) | How much protein is leaking into your urine, reflecting damage to the kidney’s filtering units |
CKD stages based on eGFR:
| Stage | eGFR Range (mL/min/1.73m²) | General Description |
| Stage 1 | 90+ (with evidence of kidney damage) | Normal or high function, but damage present |
| Stage 2 | 60-89 | Mildly reduced function |
| Stage 3a | 45-59 | Mildly to moderately reduced |
| Stage 3b | 30-44 | Moderately to severely reduced |
| Stage 4 | 15-29 | Severely reduced |
| Stage 5 | Below 15 | Kidney failure |
Albuminuria is graded separately (commonly A1, A2, A3) and combined with the eGFR stage to give a fuller risk picture, since two patients with the same eGFR but different albuminuria levels can have meaningfully different risk of progression.
Risk Over Time, Not Just a Snapshot
The single most important shift in thinking about CKD staging is this: a single number matters less than the trend. One eGFR reading can be affected by dehydration, recent illness, or lab variation. What your nephrologist actually cares about is how your eGFR and albuminuria are tracking across multiple tests over months and years.
| Pattern | What It Suggests |
| Stable eGFR over repeated tests | Lower urgency; continued monitoring and standard management |
| Gradual, consistent decline | Expected disease progression; management intensity may increase |
| Sudden, sharp drop | Warrants prompt investigation, this may reflect an acute, reversible cause rather than CKD progression itself |
| Rising albuminuria over time | Signals increasing kidney damage, even if eGFR is relatively stable |
This is why repeat testing matters more than any single result, and why patients shouldn’t panic, or become falsely reassured, based on one isolated reading.
Monitoring: What Regular Follow-Up Actually Involves in Chronic Kidney Disease Treatment
How often you’re monitored, and what’s checked, depends on your CKD stage and overall risk profile.
Typical monitoring includes:
- Repeat blood tests for eGFR/creatinine, frequency increasing as stage progresses
- Urine testing for albumin/protein levels
- Blood pressure checks at every visit, given its central role in both causing and resulting from kidney damage
- Electrolyte monitoring, particularly potassium, especially for patients on certain blood pressure medications
- Additional screening for anaemia, bone mineral disorders, and cardiovascular risk as disease progresses into later stages
| CKD Stage | General Monitoring Frequency |
| Stage 1-2 | Annually, or as guided by underlying risk factors |
| Stage 3 | Every 6 months, more often if declining |
| Stage 4-5 | Every 3 months or more frequently, with closer specialist involvement |
These are general guidelines; your actual monitoring schedule should be individualised based on your trend and risk factors, not applied mechanically.
Chronic Kidney Disease Treatment Decisions by Stage
Management intensity generally increases as CKD stage progresses, though the foundational pillars, blood pressure and blood sugar control, remain relevant at every stage.
| Stage | General Treatment Focus |
| Stage 1-2 | Risk factor control, lifestyle measures, addressing underlying cause |
| Stage 3 | Intensified blood pressure/sugar control, medication review, dietary guidance, possible SGLT2 inhibitor consideration |
| Stage 4 | Preparing for possible future renal replacement therapy discussions, managing complications (anaemia, bone disease) |
| Stage 5 | Dialysis or transplant evaluation, or conservative care discussion depending on patient circumstances and preference |
When Referral to a Nephrologist Matters
Not every CKD patient needs to see a kidney specialist immediately, primary care management is entirely appropriate for many earlier-stage, stable patients. Referral generally becomes important when:
- eGFR is declining more rapidly than expected
- Albuminuria is significant or increasing
- CKD stage reaches 4 or beyond
- The underlying cause is unclear or complex
- Difficult-to-control blood pressure or complications develop
- Planning for potential future dialysis or transplant becomes relevant
Earlier referral generally allows more time for planning and intervention, rather than referral happening only once a crisis point is reached.
Why These Numbers Matter for Any Further Chronic Kidney Disease Treatment Discussion
Whether you’re discussing standard management intensification or considering any additional option, including an assessment for regenerative approaches, your actual eGFR and albuminuria trend over time is the essential starting point. Discussions that don’t reference this documented trend aren’t grounded in your real clinical picture.
Keeping Your Own Record of Chronic Kidney Disease Treatment Results Over Time
Because trend matters more than any single reading, it’s genuinely useful to keep your own simple record of eGFR and albuminuria results over time, alongside the date of each test. This isn’t about second-guessing your doctor’s assessment, it’s about being able to see the pattern yourself, ask more specific questions during appointments, and notice if a result seems inconsistent with your recent trend, which is worth raising directly rather than assuming it’s automatically accurate. A simple spreadsheet or notes app entry each time you receive results is often enough.
Frequently Asked Questions
Is Stage 3 CKD serious?
Stage 3 covers a meaningful range (3a and 3b) and significance depends heavily on trend, cause, and albuminuria level, not the stage number alone. Discuss your specific trajectory with your doctor.
Can my CKD stage improve?
Staging reflects current function; genuine improvement in kidney filtration is uncommon in true chronic disease, though progression can often be slowed or stabilised with consistent management.
How often should I get my kidney function checked?
This depends on your stage and risk factors, ranging from annually in early stages to every few months in more advanced disease. Your doctor will individualise this.
What does rising albuminuria mean if my eGFR is stable?
It suggests ongoing kidney damage even without an obvious drop in filtration function, and often prompts closer monitoring or treatment intensification.
When should I see a nephrologist instead of my GP?
Generally once CKD reaches Stage 4, progression is faster than expected, or the underlying cause needs specialist evaluation. Your GP can guide this timing.
Does one bad lab result mean my CKD has suddenly worsened?
Not necessarily. A single reading can be affected by illness, hydration, or lab variation. Repeat testing clarifies whether it reflects a genuine trend.
Discuss Your Specific Stage With Our Team
If you’d like to understand what your specific CKD stage and trend mean for your options, request an assessment and bring your recent lab history. Learn more about chronic kidney disease at 23C Regen.